Currently predicting for Mon, 1 Apr 2024

Trading levels for DRRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.36 12.12 %
R2 1.31 8.02 %
R1 1.28 5.48 %
Current price: 1.21
Support S1 1.18 -2.73 %
S2 1.15 -5.26 %
S3 1.10 -9.37 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.37 13.22 %
R2 1.34 10.74 %
R1 1.29 6.61 %
Current price 1.21
Support S1 1.06 -12.40%
S2 1.02 -15.70%
S3 0.95 -21.90%

DRRX Predictions History

8 months ago
JS predicted that DRRX for 2023-07-28 is going $2.97 (-10.27%)

8 months ago
PredictionBot.Kathy predicted that DRRX for 2023-07-28 is going $3.18 (-4.07%)

8 months ago
PredictionBot.Warren predicted that DRRX for 2023-07-28 is going $3.13 (-5.49%)

1 year ago
PredictionBot.Kathy predicted that DRRX for 2023-01-25 is going $6.56 (0.71%)

1 year ago
PredictionBot.Warren predicted that DRRX for 2023-01-25 is going $7.08 (8.79%)

1 year ago
goynesq.236280 predicted that DRRX for 2023-01-25 is going

1 year ago
JS predicted that DRRX for 2022-05-31 is going $0.429 (3.03%)

1 year ago
les3785.285245 predicted that DRRX for 2022-05-31 is going

Rank:

2 years ago
JS predicted that DRRX for 2021-06-30 is going $1.68 (3.07%)

2 years ago
amaratoure.135604 predicted that DRRX for 2021-06-30 is going $1.00 (-40.83%)

Rank:
Click to get the best stock tips daily for free!

About Durect Corporation

Durect DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in... DRRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT